Zimmer Biomet Holdings (ZBH) Net Income towards Common Stockholders Growth (3y) (2012 - 2026)
Powered by 
Analysis
Zimmer Biomet Holdings (ZBH) Net Income towards Common Stockholders Growth (3y) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.54 Bn | 177.94 Bn | 7.27 Bn | -12.28% |
| 2 | Intuitive Surgical | 124.25 Bn | 119.03 Bn | 1.96 Bn | 24.56% |
| 3 | Medtronic | 118.34 Bn | 109.52 Bn | 6.34 Bn | 22.97% |
| 4 | Stryker | 106.50 Bn | 103.03 Bn | 4.50 Bn | 20.02% |
| 5 | Boston Scientific | 66.56 Bn | 66.02 Bn | 3.85 Bn | 51.47% |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | -7.83% |
| 7 | Alcon | 33.98 Bn | 32.52 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.07 Bn | 30.12 Bn | 830.00 Mn | 29.05% |
| 9 | Steris | 21.10 Bn | 20.61 Bn | 684.20 Mn | 17.54% |
| 10 | Zimmer Biomet Holdings | 18.27 Bn | 17.86 Bn | 1.54 Bn | -1.66% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.66% |
| Mar 31, 2026 | 0.80% |
| Dec 31, 2025 | 55.06% |
| Sep 30, 2025 | 5.99% |
| Jun 30, 2025 | -0.13% |
| Mar 31, 2025 | 133.15% |
| Dec 31, 2024 | 69.42% |
| Sep 30, 2024 | 19.56% |
| Jun 30, 2024 | 19.49% |
| Mar 31, 2024 | -4.39% |
| Dec 31, 2023 | 39.59% |
| Sep 30, 2023 | -12.87% |
| Jun 30, 2023 | 44.36% |
| Mar 31, 2023 | 34.94% |
| Dec 31, 2022 | -53.20% |
| Sep 30, 2022 | -23.40% |
| Jun 30, 2022 | 5.30% |
| Mar 31, 2022 | -61.18% |
| Dec 31, 2021 | 57.93% |
| Sep 30, 2021 | -3.47% |